UroGen Pharma Ltd.
Total Trades
47
Buys
0
Sells
25
Largest Trade
N/A
Insiders
4
Institutional Funds
116
Inst. Value
$1M+
Activist Filings
39
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Smith Jason Drew | General Counsel | SELL | $100K–$500K | 7K | $19.69 | Feb 11, 2026 |
| Smith Jason Drew | General Counsel | EXERCISE | N/A | 16K | — | Feb 11, 2026 |
| Schoenberg Mark | Chief Medical Offi… | SELL | $100K–$500K | 7K | $19.69 | Feb 5, 2026 |
| Schoenberg Mark | Chief Medical Offi… | SELL | $100K–$500K | 10K | $25.00 | Nov 20, 2025 |
| Schoenberg Mark | Chief Medical Offi… | EXERCISE | N/A | 2K | — | Sep 9, 2025 |
| Schoenberg Mark | Chief Medical Offi… | SELL | $15K–$50K | 871 | $19.11 | Sep 9, 2025 |
| Smith Jason Drew | General Counsel | SELL | $15K–$50K | 2K | $19.11 | Sep 9, 2025 |
| Smith Jason Drew | General Counsel | EXERCISE | N/A | 3K | — | Sep 9, 2025 |
| Smith Jason Drew | General Counsel | SELL | $100K–$500K | 8K | $19.14 | Jul 30, 2025 |
| Smith Jason Drew | General Counsel | EXERCISE | N/A | 17K | — | Jul 30, 2025 |
| Schoenberg Mark | Chief Medical Offi… | EXERCISE | N/A | 10K | — | Jul 30, 2025 |
| Schoenberg Mark | Chief Medical Offi… | SELL | $50K–$100K | 5K | $19.14 | Jul 30, 2025 |
| Schoenberg Mark | Chief Medical Offi… | SELL | $15K–$50K | 5K | $7.37 | Jun 11, 2025 |
| Schoenberg Mark | Chief Medical Offi… | EXERCISE | N/A | 10K | — | Jun 11, 2025 |
| Schoenberg Mark | Chief Medical Offi… | SELL | $50K–$100K | 5K | $13.08 | Jun 11, 2024 |
| Schoenberg Mark | Chief Medical Offi… | EXERCISE | N/A | 10K | — | Jun 11, 2024 |
| Schoenberg Mark | Chief Medical Offi… | SELL | $100K–$500K | 12K | $14.05 | Mar 20, 2024 |
| Smith Jason Drew | General Counsel | SELL | $50K–$100K | 5K | $15.74 | Feb 3, 2024 |
| Smith Jason Drew | General Counsel | EXERCISE | N/A | 10K | — | Feb 3, 2024 |
| Schoenberg Mark | Chief Medical Offi… | EXERCISE | N/A | 7K | — | Feb 3, 2024 |
| Schoenberg Mark | Chief Medical Offi… | SELL | $50K–$100K | 4K | $15.74 | Feb 3, 2024 |
| Smith Jason Drew | General Counsel | EXERCISE | N/A | 8K | — | Sep 5, 2023 |
| Smith Jason Drew | General Counsel | SELL | $50K–$100K | 4K | $18.01 | Sep 5, 2023 |
| Smith Jason Drew | General Counsel | EXERCISE | N/A | 3K | — | Feb 2, 2023 |
| Smith Jason Drew | General Counsel | SELL | $15K–$50K | 2K | $10.12 | Feb 2, 2023 |
| Schoenberg Mark | Chief Medical Offi… | SELL | $15K–$50K | 2K | $10.12 | Feb 2, 2023 |
| Schoenberg Mark | Chief Medical Offi… | EXERCISE | N/A | 4K | — | Feb 2, 2023 |
| Schoenberg Mark | Chief Medical Offi… | SELL | $1K–$15K | 258 | $11.85 | Nov 2, 2022 |
| Schoenberg Mark | Chief Medical Offi… | EXERCISE | N/A | 500 | — | Nov 2, 2022 |
| Smith Jason Drew | General Counsel | EXERCISE | N/A | 8K | — | Sep 2, 2022 |
| Smith Jason Drew | General Counsel | SELL | $15K–$50K | 4K | $7.21 | Sep 2, 2022 |
| Schoenberg Mark | Chief Medical Offi… | SELL | $1K–$15K | 259 | $7.81 | Aug 25, 2022 |
| Schoenberg Mark | Chief Medical Offi… | EXERCISE | N/A | 500 | — | Aug 25, 2022 |
| Schoenberg Mark | Chief Medical Offi… | SELL | $1K–$15K | 254 | $6.62 | May 3, 2022 |
| Schoenberg Mark | Chief Medical Offi… | EXERCISE | N/A | 500 | — | May 3, 2022 |
| Smith Jason Drew | General Counsel | SELL | $1K–$15K | 414 | $7.58 | Feb 2, 2022 |
| Smith Jason Drew | General Counsel | EXERCISE | N/A | 833 | — | Feb 2, 2022 |
| Henderson Molly | CFO | SELL | $1K–$15K | 331 | $7.58 | Feb 2, 2022 |
| Henderson Molly | CFO | EXERCISE | N/A | 666 | — | Feb 2, 2022 |
| Schoenberg Mark | Chief Medical Offi… | SELL | $1K–$15K | 1K | $7.58 | Feb 2, 2022 |
| Schoenberg Mark | Chief Medical Offi… | EXERCISE | N/A | 3K | — | Feb 2, 2022 |
| Barrett Elizabeth A. | CEO | EXERCISE | N/A | 18K | — | Feb 2, 2022 |
| Barrett Elizabeth A. | CEO | SELL | $50K–$100K | 8K | $7.58 | Feb 2, 2022 |
| Schoenberg Mark | Chief Medical Offi… | SELL | <$1K | 111 | $8.09 | Jan 28, 2022 |
| Schoenberg Mark | Chief Medical Offi… | EXERCISE | N/A | 209 | — | Jan 28, 2022 |
| Barrett Elizabeth A. | CEO | EXERCISE | N/A | 106K | — | Jan 7, 2022 |
| Barrett Elizabeth A. | CEO | SELL | $100K–$500K | 47K | $9.15 | Jan 7, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 116 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Jefferies Financial Group Inc. | 2.2M | $1M+ | SH |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1.7M | $1M+ | SH |
| SG Americas Securities, LLC | 1.4M | $1M+ | SH |
| AMERICAN CENTURY COMPANIES INC | 1.4M | $1M+ | SH |
| MENORA MIVTACHIM HOLDINGS LTD. | 1.2M | $1M+ | SH |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 1.1M | $1M+ | SH |
| MPM BioImpact LLC | 941K | $1M+ | SH |
| ORBIMED ADVISORS LLC | 875K | $1M+ | SH |
| STATE STREET CORP | 807K | $1M+ | SH |
| Migdal Insurance & Financial Holdings Ltd. | 771K | $1M+ | SH |
| J. Goldman & Co LP | 513K | $1M+ | SH |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 435K | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 434K | $1M+ | SH |
| TANG CAPITAL MANAGEMENT LLC | 350K | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 244K | $1M+ | SH |
| Privium Fund Management B.V. | 215K | $1M+ | SH |
| Hennion & Walsh Asset Management, Inc. | 162K | $1M+ | SH |
| Informed Momentum Co LLC | 160K | $1M+ | SH |
| Soleus Capital Management, L.P. | 150K | $1M+ | SH |
| AQR CAPITAL MANAGEMENT LLC | 141K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Feb 13, 2026
4.9%
2.3M shares
Paradigm BioCapital Advisors LP
SC 13G/A · Nov 14, 2025
9.0%
4.2M shares
SC 13G · Nov 14, 2025
6.9%
3.2M shares
SC 13G/A · Nov 14, 2025
0.0%
0 shares
SC 13G/A · Aug 14, 2025
0.0%
0 shares
Paradigm BioCapital Advisors LP
SC 13G · Aug 12, 2025
5.0%
2.3M shares
SC 13G · Aug 6, 2025
5.4%
2.5M shares
Soleus Capital Master Fund, L.P.
SC 13G/A · Aug 5, 2025
4.7%
2.2M shares
SC 13G/A · Jul 29, 2025
6.9%
3.2M shares
SC 13G/A · Jul 16, 2025
5.0%
2.3M shares
Soleus Capital Master Fund, L.P.
SC 13G · Jun 16, 2025
5.0%
2.3M shares
SC 13G · Jun 13, 2025
5.8%
2.7M shares
Monograph Capital Partners I, L.P.
SC 13D/A · Jun 9, 2025
1.8%
839K shares
SC 13G/A · May 15, 2025
7.0%
3.2M shares
Adage Capital Management, L.P.
SC 13G/A · May 12, 2025
2.8%
1.3M shares
SC 13G/A · Mar 17, 2025
5.0%
2.3M shares
Adage Capital Management, L.P.
SC 13G/A · Feb 12, 2025
6.9%
2.9M shares
SC 13G/A · Feb 5, 2025
1.8%
753K shares
Pontifax Management III G.P. (2011) Ltd.
SC 13D/A · Nov 18, 2024
4.4%
11.5M shares
Point72 Asset Management, L.P.
SC 13G/A · Nov 15, 2024
3.6%
1.5M shares
SC 13G/A · Nov 14, 2024
7.1%
3.2M shares
SC 13G/A · Nov 14, 2024
1.8%
759K shares
Menora Mivtachim Holdings Ltd.
SC 13G/A · Nov 14, 2024
5.5%
2.3M shares
SC 13G/A · Nov 14, 2024
10.0%
4.9M shares
Adage Capital Management, L.P.
SC 13G · Nov 12, 2024
8.9%
3.7M shares
Morgan Stanley I.R.S. # 36-3145972
SC 13G · Nov 6, 2024
5.2%
2.2M shares
SC 13G/A · Feb 14, 2024
10.0%
3.1M shares
SC 13G/A · Feb 14, 2024
8.5%
2.6M shares
Menora Mivtachim Holdings Ltd.
SC 13G/A · Feb 14, 2024
7.5%
2.3M shares
Stonepine Capital Management, LLC
SC 13G/A · Feb 14, 2024
0.0%
0 shares
SC 13G · Feb 14, 2024
5.6%
1.7M shares
SC 13G · Dec 29, 2023
10.0%
3.1M shares
SC 13G · Sep 15, 2023
8.5%
2.6M shares
Monograph Capital Partners I, L.P.
SC 13D · Aug 4, 2023
5.1%
1.6M shares
Menora Mivtachim Holdings Ltd.
SC 13G/A · Jun 12, 2023
12.4%
2.9M shares
Stonepine Capital Management, LLC
SC 13G/A · Feb 13, 2023
5.7%
1.3M shares
Stonepine Capital Management, LLC
SC 13G · Dec 2, 2022
5.2%
1.2M shares
Wildcat Capital Management, LLC
SC 13G/A · Feb 14, 2022
2.4%
533K shares
SC 13G/A · Feb 14, 2022
4.8%
1.1M shares